1
|
Sánchez-García JC, Carrascosa Moreno NP, Tovar-Gálvez MI, Cortés-Martín J, Liñán-González A, Alvarado Olmedo L, Rodríguez-Blanque R. COVID-19 in Pregnant Women, Maternal-Fetal Involvement, and Vertical Mother-to-Child Transmission: A Systematic Review. Biomedicines 2022; 10:biomedicines10102554. [PMID: 36289816 PMCID: PMC9599127 DOI: 10.3390/biomedicines10102554] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2022] [Revised: 09/22/2022] [Accepted: 10/09/2022] [Indexed: 11/16/2022] Open
Abstract
Pregnant women are included in the COVID-19 risk groups even if they do not have any pathology. This requires an analysis of research focused on pregnant women to understand the impact of SARS-CoV-2 on their condition. There is also a need to know whether there is vertical mother-to-child transmission, as well as other consequences in case the pregnant woman is infected and COVID-19 positive. A systematic review was carried out to analyze the existing information on the complications of a pregnant woman infected with the SARS-CoV-2 coronavirus and the possibility of vertical transmission from mother to child, registered in the PROSPERO website and searched in the PubMed, Scopus, CINAHL, and Cochrane Library databases. Finally, 22 articles were included in the review. The review suggests that vertical transmission from mother to child could be exceptionally possible at the time of delivery or breastfeeding, but not through the placenta. It is interesting to point out the good acceptance of vaccination by pregnant women, which may be the reason for the low infectivity. Further research on pregnant women should be carried out to provide evidence on vertical mother-to-child transmission and the role of breast milk in relation to SARS-CoV-2.
Collapse
Affiliation(s)
- Juan Carlos Sánchez-García
- Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, 41006 Sevilla, Spain
- Nursing Department, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain
| | | | - María Isabel Tovar-Gálvez
- Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, 41006 Sevilla, Spain
- Nursing Department, Faculty of Health Sciences in Ceuta, University of Granada, 51001 Ceuta, Spain
- Correspondence:
| | - Jonathan Cortés-Martín
- Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, 41006 Sevilla, Spain
- Nursing Department, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain
| | - Antonio Liñán-González
- Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, 41006 Sevilla, Spain
- Nursing Department, Faculty of Health Sciences in Melilla, University of Granada, Melilla Campus, 52005 Melilla, Spain
| | - Leticia Alvarado Olmedo
- Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, 41006 Sevilla, Spain
- Nursing Department, Faculty of Health Sciences in Ceuta, University of Granada, 51001 Ceuta, Spain
| | - Raquel Rodríguez-Blanque
- Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, 41006 Sevilla, Spain
- Nursing Department, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain
| |
Collapse
|
2
|
Teelucksingh S, Nana M, Nelson-Piercy C. Managing COVID-19 in pregnant women. Breathe (Sheff) 2022; 18:220019. [PMID: 36337130 PMCID: PMC9584589 DOI: 10.1183/20734735.0019-2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Accepted: 07/05/2022] [Indexed: 12/15/2022] Open
Abstract
Principles of management of COVID-19 in the general population apply in pregnancy with few exceptions. Clinical inertia can lead to preventable morbidity and mortality. COVID-19 vaccines are safe and should be recommended at any stage of pregnancy. https://bit.ly/3Rj8nWr.
Collapse
Affiliation(s)
| | - Melanie Nana
- Dept of Obstetric Medicine, St Thomas’ Hospital, London, UK
- Dept of Women and Children's Health, King's College London, London, UK
| | - Catherine Nelson-Piercy
- Dept of Obstetric Medicine, St Thomas’ Hospital, London, UK
- Dept of Women and Children's Health, King's College London, London, UK
| |
Collapse
|
3
|
Joubert E, Kekeh AC, Amin CN. COVID-19 and novel mRNA vaccines in pregnancy: an updated literature review. BJOG 2021; 129:21-28. [PMID: 34651406 PMCID: PMC8652509 DOI: 10.1111/1471-0528.16973] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 09/23/2021] [Accepted: 10/05/2021] [Indexed: 01/01/2023]
Abstract
The novel coronavirus, SARS‐CoV‐2, or COVID‐19, has affected the world on a pandemic scale resulting in catastrophic outcomes and deaths. Currently, there is limited safety data specific to mRNA vaccine use in pregnant or lactating individuals and the potential risks to a pregnant individual and the fetus are unknown. We report an updated literature review of current information and evidence available to aid in the decision whether to vaccinate against COVID‐19 currently being made by pregnant individuals and their healthcare providers so that they are able to make a well‐informed recommendation and decision.
Collapse
Affiliation(s)
- E Joubert
- Campbell University School of Osteopathic Medicine, Lillington, NC, USA
| | - A C Kekeh
- Edward Via College of Osteopathic Medicine-Virginia Campus, Blacksburg, VA, USA
| | - C N Amin
- Piedmont Family Medicine, Salisbury, NC, USA
| |
Collapse
|
4
|
Franchini M, Prefumo F, Grisolia G, Bergamini V, Glingani C, Pisello M, Presti F, Zaffanello M. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review. Viruses 2021; 13:1194. [PMID: 34206468 PMCID: PMC8310344 DOI: 10.3390/v13071194] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2021] [Revised: 06/17/2021] [Accepted: 06/17/2021] [Indexed: 12/23/2022] Open
Abstract
The treatment of COVID-19 is particularly critical in pregnant women, considering the potential teratogenic effects of antiviral agents and the immune-depression related with pregnancy. The aim of this review is to systematically examine the current evidence on the clinical use of convalescent plasma during pregnancy. The electronic databases Medline PubMed Advanced Search Builder, Scopus, Web Of Science and Google Scholar were searched (until 1 January 2021). Inclusion criteria were pregnant women with COVID-19 (or SARS-CoV-2 infection), in whom convalescent plasma (or hyperimmune plasma) was used as treatment. We searched clinical trial registries (censored 5 January 2021) for eligible studies under way. After elimination of duplications, the initial search yielded 79 potentially relevant records, of which 67 were subsequently excluded. The 12 remaining records were case reports involving 12 pregnancies. Six of the mothers were reported to be well, two were reported to have preeclampsia, and in one case each the maternal outcome was described as survival, clinical improvement, discharged with oxygen and rehabilitation. With regard to the neonates, two were declared to be well, four had transient morbidity, two were critically ill and one died; normal ongoing pregnancies, but no post-delivery information, were reported for the remaining three cases. Clinical trials under way or planned to investigate the use of convalescent plasma for COVID-19 during pregnancy are lacking. This is the first systematic review of the literature regarding the treatment of COVID-19 in pregnancy. The published literature data seem to indicate that convalescent plasma administered to pregnant women with severe COVID-19 provides benefits for both the mother and the fetus. The quality of the available studies is, however, very limited since they are all case reports and thus suffer from relevant reporting bias.
Collapse
Affiliation(s)
- Massimo Franchini
- Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, I-46100 Mantova, Italy; (M.F.); (C.G.)
| | - Federico Prefumo
- Department of Clinical and Experimental Sciences, University of Brescia, I-25123 Brescia, Italy;
| | - Gianpaolo Grisolia
- Obstetrics and Gynecology Unit, Carlo Poma Hospital, I-46100 Mantova, Italy; (G.G.); (M.P.)
| | - Valentino Bergamini
- Department of Obstetrics and Gynecology, Azienda Ospedaliera Universitaria Integrata, I-37126 Verona, Italy; (V.B.); (F.P.)
| | - Claudia Glingani
- Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, I-46100 Mantova, Italy; (M.F.); (C.G.)
| | - Marlene Pisello
- Obstetrics and Gynecology Unit, Carlo Poma Hospital, I-46100 Mantova, Italy; (G.G.); (M.P.)
| | - Francesca Presti
- Department of Obstetrics and Gynecology, Azienda Ospedaliera Universitaria Integrata, I-37126 Verona, Italy; (V.B.); (F.P.)
| | - Marco Zaffanello
- Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, I-37126 Verona, Italy
| |
Collapse
|